Chemed ROA 2010-2024 | CHE

Current and historical return on assets (ROA) values for Chemed (CHE) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Chemed ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $0.30B $1.77B 17.51%
2024-06-30 $0.30B $1.74B 17.99%
2024-03-31 $0.28B $1.73B 17.52%
2023-12-31 $0.27B $1.67B 17.65%
2023-09-30 $0.24B $1.56B 16.43%
2023-06-30 $0.23B $1.51B 15.77%
2023-03-31 $0.24B $1.43B 17.25%
2022-12-31 $0.25B $1.44B 18.39%
2022-09-30 $0.26B $1.36B 19.71%
2022-06-30 $0.28B $1.31B 20.98%
2022-03-31 $0.27B $1.31B 20.03%
2021-12-31 $0.27B $1.34B 19.55%
2021-09-30 $0.31B $1.32B 22.02%
2021-06-30 $0.30B $1.38B 21.55%
2021-03-31 $0.33B $1.46B 23.71%
2020-12-31 $0.32B $1.44B 23.83%
2020-09-30 $0.27B $1.37B 20.91%
2020-06-30 $0.26B $1.29B 20.75%
2020-03-31 $0.23B $1.28B 19.04%
2019-12-31 $0.22B $1.27B 18.95%
2019-09-30 $0.21B $1.23B 19.12%
2019-06-30 $0.20B $1.09B 19.52%
2019-03-31 $0.21B $1.07B 20.74%
2018-12-31 $0.21B $0.98B 21.60%
2018-09-30 $0.21B $0.98B 22.03%
2018-06-30 $0.19B $0.93B 20.79%
2018-03-31 $0.11B $0.91B 12.42%
2017-12-31 $0.10B $0.92B 10.86%
2017-09-30 $0.08B $0.90B 8.40%
2017-06-30 $0.07B $0.91B 7.62%
2017-03-31 $0.11B $0.89B 13.18%
2016-12-31 $0.11B $0.88B 12.61%
2016-09-30 $0.11B $0.84B 12.48%
2016-06-30 $0.11B $0.85B 12.51%
2016-03-31 $0.11B $0.88B 12.62%
2015-12-31 $0.11B $0.85B 12.57%
2015-09-30 $0.11B $0.90B 12.55%
2015-06-30 $0.11B $0.89B 12.19%
2015-03-31 $0.10B $0.90B 12.00%
2014-12-31 $0.10B $0.86B 11.62%
2014-09-30 $0.09B $0.87B 10.71%
2014-06-30 $0.09B $0.84B 9.75%
2014-03-31 $0.08B $0.87B 8.58%
2013-12-31 $0.08B $0.89B 8.62%
2013-09-30 $0.08B $0.88B 9.15%
2013-06-30 $0.09B $0.90B 9.65%
2013-03-31 $0.09B $0.90B 10.54%
2012-12-31 $0.09B $0.86B 10.51%
2012-09-30 $0.09B $0.87B 10.59%
2012-06-30 $0.09B $0.83B 10.88%
2012-03-31 $0.09B $0.83B 10.69%
2011-12-31 $0.09B $0.80B 10.47%
2011-09-30 $0.08B $0.82B 10.00%
2011-06-30 $0.08B $0.85B 9.64%
2011-03-31 $0.08B $0.82B 9.48%
2010-12-31 $0.08B $0.83B 9.51%
2010-09-30 $0.08B $0.90B 8.96%
2010-06-30 $0.08B $0.87B 8.98%
2010-03-31 $0.07B $0.85B 8.98%
2009-12-31 $0.07B $0.82B 9.21%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.238B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00